Heartseed Inc. (TYO:219A)

Japan flag Japan · Delayed Price · Currency is JPY
3,555.00
-125.00 (-3.40%)
Aug 1, 2025, 3:30 PM JST
-3.40%
Market Cap80.23B
Revenue (ttm)2.64B
Net Income (ttm)614.54M
Shares Out22.57M
EPS (ttm)28.21
PE Ratio126.01
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume494,100
Average Volume1,034,975
Open3,650.00
Previous Close3,680.00
Day's Range3,555.00 - 3,700.00
52-Week Range901.00 - 4,385.00
Betan/a
RSI57.81
Earnings DateSep 11, 2025

About Heartseed

Heartseed Inc. develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure. The company’s lead product candidate is HS-001 for heart failure with reduced ejection fraction indications, including dilated cardiomyopathy, old myocardial infraction, and dilated phase of hypertrophic cardiomyopathy. It also develops products using autologous iPSC and HLA knock-out iPSC. The company was incorporated in 2015 and is headquartered in Tokyo, Japan. [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 2015
Country Japan
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 219A
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.